Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva, Active extend pact on oral MS therapy
Marketwatch
Monday, February 8, 2010 - 11:36am
tags:
Teva Pharmaceuticals, Active Biotech, partnerships, MS, multiple sclerosis
Vermont mulls free-sample disclosure rule
Fierce Pharma
Monday, February 8, 2010 - 11:35am
tags:
Vermont, samples
EU Approval for Merck's Elonva
Yahoo/AP
Monday, February 8, 2010 - 11:34am
tags:
Europe, Merck, fertility drugs, Elonva
SciClone drug sustains swine flu shot in study
Yahoo/AP
Monday, February 8, 2010 - 10:19am
tags:
SciClone, swine flu, H1N1
Broker comments lift pharma stocks
FT.com
Monday, February 8, 2010 - 10:16am
tags:
drug stocks, Teva Pharmaceuticals, GSK, Pfizer, Shire, UCB Pharmaceuticals, Merck KGaA
Eventful Year Expected for Access Pharma
Seeking Alpha
Monday, February 8, 2010 - 9:41am
tags:
Access Pharmaceuticals, cancer
Novavax, Rovi end flu-vaccine-development plan
Marketwatch
Monday, February 8, 2010 - 9:39am
tags:
Novavax, Rovi, Flu, vaccines, partnerships
Lilly's Cialis meets with success, challenges
Indianapolis Star, IN
Monday, February 8, 2010 - 9:37am
tags:
Eli Lilly, Cialis, erectile dysfunction
Sanofi to decide soon on reviving Merck venture
WSJ Online
Monday, February 8, 2010 - 9:35am
tags:
Sanofi, Merck, joint ventures, animal health
Large Pharma and Small Biotech Deals Expected to Increase in 2010
Seeking Alpha
Monday, February 8, 2010 - 9:31am
tags:
Sanofi, AstraZeneca, Pfizer, Generex
Pfizer launches e-payment system
FT.com
Monday, February 8, 2010 - 9:29am
tags:
Pfizer
How Big Pharma Got in This Fix
Seeking Alpha
Sunday, February 7, 2010 - 11:50am
tags:
Big Pharma
Teva allocates $315m for Medicaid settlement
Globes, Israel
Sunday, February 7, 2010 - 11:44am
tags:
Teva Pharmaceuticals
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophy
Medical News Today
Sunday, February 7, 2010 - 11:42am
tags:
AVI BioPharma, orphan drugs, Duchenne Muscular Dystrophy
Bioheart Launches First US FDA Approved Clinical Trial That Tests Gene-Modified Stem Cell Therapy In Patients With Congestive Heart Failure
Medical News Today
Sunday, February 7, 2010 - 11:36am
tags:
Bioheart, stem cells, congestive heart failure
Killing research no certain cure for Big Pharma
Economic Times, India
Saturday, February 6, 2010 - 1:05pm
tags:
Big Pharma
Teva’s Needle-Free Tjet® Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment
Health News Digest
Saturday, February 6, 2010 - 1:03pm
tags:
Teva Pharmaceuticals, growth hormone deficiency
Radient Pharmaceuticals Announces Onko-Sure In Vitro Diagnostic Cancer Test Sales for Q1 2010 on Track
PR Canada
Saturday, February 6, 2010 - 1:02pm
tags:
Radient Pharmaceuticals, Onko-Sure
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Medical News Today
Saturday, February 6, 2010 - 12:52pm
tags:
Qiagen, Pfizer, glioblastoma multiforme
FDA OKs Javelin Pharmaceuticals' Dyloject NDA for Formal Review
Trading Markets
Saturday, February 6, 2010 - 12:41pm
tags:
Javelin, Dyloject, painkillers

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.